Technology | January 21, 2014

American MD Labs Launches Professional Products for Radiation Therapy Patients

HA85 PUR Relief is first FDA-registered skin care product for chemotherapy, radiation burns

American MD Labs HA85 PUR Relief Radiation Therapy
January 21, 2013 — American MD Labs’ HA85 PUR Relief skin care products are formulated to soothe symptoms related to chemotherapy and radiation treatment such as extremely dry skin, burns and muscle pain. 
 
HA85 PUR Relief contains hyaluronan, a naturally occurring polysaccharide that repairs skin tissues by embedding cells and fibrous constituents such as collagen and elastin. Hyaluronan binds 1,000 times its weight in water, which can contribute to skin tissue hydration. HA85 PUR Relief uses three different molecular weights of hyaluronan: 1 million daltons, 50,000 daltons and 5,000 daltons, which work on, under and deep under the surface of the skin, respectively. 
 
HA85 PUR Relief combines peptide technology with quaternary ammines to restore cellular membrane balance and treat radiation burns. HA85 PUR Relief’s key ingredients are designed to mimic the skin’s structure and auto-adjust pH to optimize production of enzymes that naturally heal wounds and promote skin homeostasis. 
 
Allantoin works as an anti-irritant and skin protectant, increases water content of the extracellular matrix and promotes cell replication. 
 
HA85 PUR Relief endeavors to provide deep hydration, relief and protection before, during and after treatment. The HA85 PUR Relief Professional Series will be available in both gel and spray applications and are water-free.
 
For more information: purrelief.com

Related Content

ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...